Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Growth source : Www.biospace.com save search
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
BIAF | $2.4 -7.34% -7.92% 110K
|
|
| O: -2.7%
H: 5.56%
C: -2.78%
development growth
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
Published: 2024-04-24 (Crawled : 09:00) - biospace.com/
EVO | $5.22 -31.77% -46.55% 1.5M
|
Manufacturing
|
| O: -32.16%
H: 3.85%
C: 0.77%
reset year profitable results growth
Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
Published: 2024-04-22 (Crawled : 12:00) - biospace.com/
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
revenue growth
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Published: 2024-04-19 (Crawled : 21:00) - biospace.com/
NOVT | $157.9 -0.93% -0.94% 110K
|
Electronic Technology
|
| O: -3.53%
H: 1.09%
C: 0.25%
conference growth
Stemtech Corporation on Track for CEO and Chairman's Goal for Growth and Global Expansion
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
STEK | $0.0535 -62.89% 1.3M
|
n/a
|
| O: 0.0%
H: 0.0%
C: -14.29%
ceo corporation expansion global for growth
Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
ENSC | $0.5583 1.58% 43K
|
Health Technology
|
| O: -5.53%
H: 0.0%
C: -6.56%
conference presentation growth
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
IINN | $1.925 3.5% 3.38% 130K
|
Manufacturing
|
| O: 2.06%
H: 19.19%
C: 5.05%
bloodstream infections results show growth study
Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
SYRA | $1.05 5.86% 5.53% 1.3M
|
n/a
|
| O: -2.33%
H: 0.6%
C: -10.71%
health revenue financial growth
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Published: 2024-03-19 (Crawled : 12:00) - biospace.com/
SSKN | $0.549 1.67% 1.64% 5.6K
|
Health Technology
|
| O: 1.28%
H: 9.63%
C: -2.2%
avoid family growth
Parexel Announces CEO Succession PlanChief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024
Published: 2024-03-18 (Crawled : 15:00) - biospace.com/
TNDM | $35.12 0.43% 0.43% 1M
|
Health Technology
|
| O: 0.7%
H: 8.21%
C: 7.98%
ceo growth
UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
Published: 2024-03-14 (Crawled : 13:00) - biospace.com/
URGN | $14.24 -2.0% -2.04% 97K
|
Health Technology
|
| O: -4.01%
H: 0.69%
C: -14.55%
ugn-102 jelmyto pharma company growth submission
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
RGBP | $0.7 5.69% 1.5K
|
Manufacturing
|
| O: 1.51%
H: 11.2%
C: 7.5%
conference growth
Dermata to Present at the Emerging Growth Conference on February 7, 2024
Published: 2024-02-01 (Crawled : 20:00) - biospace.com/
DRMA | $0.3397 -2.75% 17K
|
|
| O: -3.67%
H: 0.0%
C: -3.11%
conference growth
Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products
Published: 2024-02-01 (Crawled : 09:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: -1.98%
fy2023 management momentum growth
Niterra Leads $10M Growth Funding Round for Imbed Biosciences
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
NGKSF | $21.61 0% 100
|
n/a
| Email alert
Add to watchlist
NGKSY | $15.64 -35.1% 220
|
n/a
| Email alert
Add to watchlist
funding growth
Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.55%
H: 1.45%
C: 1.42%
conference business growth
Zynex to Participate at the Needham Annual Growth Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
ZYXI | $11.245 -0.13% -0.13% 130K
|
Health Technology
|
| O: 0.65%
H: 4.24%
C: 2.21%
conference growth
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
Published: 2023-12-19 (Crawled : 15:30) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.66%
H: 17.46%
C: 13.07%
ceo innovation growth
J&J Expects Up to 6% Growth Next Year with 20-Plus New Drugs by 2030
Published: 2023-12-05 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
year growth
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
RGBP | $0.7 5.69% 1.5K
|
Manufacturing
|
| O: -3.39%
H: 4.39%
C: 1.75%
conference growth
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.